Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage
Bérengère de Laval, Patrycja Pawlikowska, Laurence Petit-Cocault, Chrystèle Bilhou-Nabera, Geneviève Aubin-Houzelstein, Michèle Souyri, Frédéric Pouzoulet, Murielle Gaudry, Françoise Porteu, Bérengère de Laval, Patrycja Pawlikowska, Laurence Petit-Cocault, Chrystèle Bilhou-Nabera, Geneviève Aubin-Houzelstein, Michèle Souyri, Frédéric Pouzoulet, Murielle Gaudry, Françoise Porteu
Abstract
DNA double-strand breaks (DSBs) represent a serious threat for hematopoietic stem cells (HSCs). How cytokines and environmental signals integrate the DNA damage response and contribute to HSC-intrinsic DNA repair processes remains unknown. Thrombopoietin (TPO) and its receptor, Mpl, are critical factors supporting HSC self-renewal and expansion. Here, we uncover an unknown function for TPO-Mpl in the regulation of DNA damage response. We show that DNA repair following γ-irradiation (γ-IR) or the action of topoisomerase-II inhibitors is defective in Mpl(-/-) and in wild-type mouse or human hematopoietic stem and progenitor cells treated in the absence of TPO. TPO stimulates DNA repair in vitro and in vivo by increasing DNA-PK-dependent nonhomologous end-joining efficiency. This ensures HSC chromosomal integrity and limits their long-term injury in response to IR. This shows that niche factors can modulate the HSC DSB repair machinery and opens new avenues for administration of TPO agonists for minimizing radiotherapy-induced HSC injury and mutagenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.
Source: PubMed